GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Modalis Therapeutics Corp (TSE:4883) » Definitions » FCF Yield %

Modalis Therapeutics (TSE:4883) FCF Yield % : -36.48 (As of Dec. 12, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Modalis Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Modalis Therapeutics's Trailing 12-Month Free Cash Flow is 円-2,294.17 Mil, and Market Cap is 円6,288.56 Mil. Therefore, Modalis Therapeutics's FCF Yield % for today is -36.48%.

The historical rank and industry rank for Modalis Therapeutics's FCF Yield % or its related term are showing as below:

TSE:4883' s FCF Yield % Range Over the Past 10 Years
Min: -106.5   Med: 0   Max: 0
Current: -36.48


TSE:4883's FCF Yield % is ranked worse than
91.15% of 1039 companies
in the Drug Manufacturers industry
Industry Median: 0.13 vs TSE:4883: -36.48

Modalis Therapeutics's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.


Modalis Therapeutics FCF Yield % Historical Data

The historical data trend for Modalis Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modalis Therapeutics FCF Yield % Chart

Modalis Therapeutics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial - -1.91 -4.81 -21.28 -55.47

Modalis Therapeutics Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Modalis Therapeutics's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Modalis Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Modalis Therapeutics's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Modalis Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Modalis Therapeutics's FCF Yield % falls into.



Modalis Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Modalis Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-2294.165 / 4136.0448
=-55.47%

Modalis Therapeutics's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0 * 4 / 2760.709
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Modalis Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Modalis Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Modalis Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Modalis Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
16-5 Nihombashi-Kabuto-cho, Chuo-ku, Tokyo, JPN, 103-0026
Modalis Therapeutics Corp is a drug development company. It is engaged in research and development of Gene Therapy using core platform technology, non-editing CRISPR technology (CRISPR-GNDM). The company's products in pipeline are MDL-201, MDL-202, MDL-204, MDL-205, MDL-206, MDL-101, and MDL-102.

Modalis Therapeutics Headlines

No Headlines